IPP Bureau
Novartis to launch DTP platform for Cosentyx in US
By IPP Bureau - October 01, 2025
Through the new DTP platform, Novartis will make Cosentyx available to patients at a price that reflects the average savings typically retained by insurers and pharmacy benefit managers
ACL Digital acquires US-based CRO Symbiance to expand clinical research capabilities
By IPP Bureau - October 01, 2025
The acquisition positions ACL Digital as an end-to-end provider of global clinical research and data CRO solutions
Lupin receives FDA approval Rivaroxaban for oral suspension
By IPP Bureau - October 01, 2025
The product will be manufactured at Lupin’s Chhatrapati Sambhajinagar facility in India
Pfizer agrees to slash prescription drug prices for Americans
By IPP Bureau - October 01, 2025
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
AbbVie begins construction of $70 million biologics manufacturing site in US
By IPP Bureau - October 01, 2025
The expansion will significantly enhance AbbVie’s ability to meet growing global demand for biologics, particularly in oncology and immunology
DPIIT and Thermo Fisher Scientific launch BioVerse challenge to fast-track India’s biotech future
By IPP Bureau - October 01, 2025
India currently hosts more than 10,075 biotech startups
AbbVie seeks FDA approval for Pivekimab Sunirine to treat rare, aggressive blood cancer
By IPP Bureau - October 01, 2025
BPDCN is a challenging blood cancer with characteristics of both leukemia and lymphoma
Winrevair cuts risk of PAH progression by 76% in phase 3 Hyperion trial
By IPP Bureau - October 01, 2025
Hyperion results presented at ERS 2025 and simultaneously published in the New England Journal of Medicine
Wockhardt submits drug application to FDA for Zidebactam-Cefepime for treatment of serious Gram-negative infections
By IPP Bureau - October 01, 2025
This milestone marks the first-ever NDA submission to the U.S. FDA for a drug, fully discovered and developed by an Indian pharmaceutical company
GSK names Luke Miels as next CEO
By IPP Bureau - September 30, 2025
Miels will formally assume the role on January 1, 2026
BMS launches BMS patient connect, expands direct-to-patient access with Sotyktu
By IPP Bureau - September 30, 2025
Eliquis (apixaban) available at more than 40 per cent discount; Sotyktu to be offered at more than 80 per cent discount to current list price
Gleneagles Hospital Mumbai and Medtronic host conclave on hub & spoke model and AI in healthcare
By IPP Bureau - September 30, 2025
The Hub & Spoke model is designed to extend advanced medical care to a wider community
Brenntag showcases innovations in beauty and personal care at Indonesia Cosmetic Ingredients 2025
By IPP Bureau - September 30, 2025
Brenntag will showcase forward-looking formulations designed to respond to Indonesia’s evolving beauty and self-care needs
